ArticleDiving and hyperbaric medicine2025
The effect of hyperbaric oxygen therapy on lesion size in early-stage femoral head avascular necrosis.
Article in Diving and hyperbaric medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Femoral head avascular necrosis (AVN) is a common orthopaedic condition that occurs when intraosseous microcirculation is compromised. Hyperbaric oxygen therapy (HBOT) increases tissue oxygen concentration, reduces oedema, stimulates angiogenesis, lowers intraosseous pressure, and enhances microcirculation. The aim of this study was to evaluate the effectiveness of HBOT in early femoral head AVN based on magnetic resonance imaging (MRI) findings. Methods: A total of 37 hips from 25 patients with Ficat Stage 1-2 femoral head AVN, followed between 2018 and 2021 and receiving HBOT at Kayseri City Training and Research Hospital, were retrospectively included. Thirty HBOT sessions of 90 minutes each were administered at 243 kPa pressure (2.4 atmospheres absolute) with 100% oxygen breathing, along with a weight-bearing restriction protocol. Results: There were 20 females and five males. The mean (standard deviation) age was 46.9 (9.5). In pre-treatment MRI imaging, the mean lesion size was 29.87 (22.64) cm³ in 20 right hips and 28.84 (14.95) cm³ in 17 left hips (P = 0.183). At the second month after treatment, the lesion size was 12.39 (11.26) cm³ in 20 right hips and 21.81 (13.56) cm³ in 17 left hips (P < 0.001). The mean pre-post differences for the right and left hips was 17.48 (21.15) cm³ and 7.02 (5.95) cm3 respectively (both P < 0.001). Conclusions: Femoral head AVN is a progressive disease, with femoral head collapse exceeding 40% in a five-year follow-up. This study demonstrated a reduction in lesion size associated with HBOT in early stage femoral head AVN. In our opinion, HBOT is an integral part of the treatment for early-stage femoral avascular necrosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.